Threonine 48 in the BIR Domain of Survivin is Critical to Its Mitotic and Anti-apoptotic Activities and Can Be Phosphorylated by CK2 in Vitro

Overview

Journal Cell Cycle

Specialty Cell Biology

Date 2011 Jan 22

PMID 21252625

Citations 20

Authors

Rachel M A Barrett

Rita Colnaghi

Sally P Wheatley

Affiliations

Soon will be listed here.

Abstract

In this study we report that the protein kinase CK2 phosphorylates survivin specifically on threonine 48 (T48) within its BIR domain, and that T48 is critical to both the mitotic and anti-apoptotic roles of survivin. Interestingly, during mitosis T48 mutants localise normally, but are unable to support cell growth when endogenous survivin is removed by siRNA. In addition, while overexpression of survivin normally confers inhibition of TRAIL-mediated apoptosis, this protection is abolished by mutation of T48. Furthermore in interphase cells depletion of endogenous survivin causes redistribution of T48 mutants from the cytoplasm to the nucleus and treatment of cells expressing survivin-GFP with the CK2 inhibitor TBB phenocopies this nuclear redistribution. Finally, we show T48 mutants have increased affinity for borealin, and that this association and cell proliferation can be restored by introduction of a second mutation at T97. To our knowledge these data are the first to identify T48 as a key regulatory site on survivin, and CK2 as a mediator of its mitotic and anti-apoptotic functions.

Citing Articles

Survivin as a Therapeutic Target for the Treatment of Human Cancer.

Wang Q, Greene M Cancers (Basel). 2024; 16(9).

PMID: 38730657 PMC: 11083197. DOI: 10.3390/cancers16091705.

Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocket.

Bancet A, Frem R, Jeanneret F, Mularoni A, Bazelle P, Roelants C iScience. 2024; 27(2):108903.

PMID: 38318383 PMC: 10838953. DOI: 10.1016/j.isci.2024.108903.

Minor Kinases with Major Roles in Cytokinesis Regulation.

Sechi S, Piergentili R, Giansanti M Cells. 2022; 11(22).

PMID: 36429067 PMC: 9688779. DOI: 10.3390/cells11223639.

CK2 and the Hallmarks of Cancer.

Firnau M, Brieger A Biomedicines. 2022; 10(8).

PMID: 36009534 PMC: 9405757. DOI: 10.3390/biomedicines10081987.

Discovering and Characterizing of Survivin Dominant Negative Mutants With Stronger Pro-apoptotic Activity on Cancer Cells and CSCs.

Guo W, Ma X, Fu Y, Liu C, Liu Q, Hu F Front Oncol. 2021; 11:635233.

PMID: 33869021 PMC: 8045750. DOI: 10.3389/fonc.2021.635233.

References

Faust M, Gunther J, Morgenstern E, Montenarh M, Gotz C . Specific localization of the catalytic subunits of protein kinase CK2 at the centrosomes. Cell Mol Life Sci. 2003; 59(12):2155-64. PMC: 11146106. DOI: 10.1007/s000180200022. View

Yu I, Spector D, Bae Y, Marshak D . Immunocytochemical localization of casein kinase II during interphase and mitosis. J Cell Biol. 1991; 114(6):1217-32. PMC: 2289133. DOI: 10.1083/jcb.114.6.1217. View

Verdecia M, Huang H, Dutil E, Kaiser D, Hunter T, Noel J . Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat Struct Biol. 2000; 7(7):602-8. DOI: 10.1038/76838. View

Wang F, Dai J, Daum J, Niedzialkowska E, Banerjee B, Stukenberg P . Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis. Science. 2010; 330(6001):231-5. PMC: 2967368. DOI: 10.1126/science.1189435. View

Wheatley S, Carvalho A, Vagnarelli P, Earnshaw W . INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis. Curr Biol. 2001; 11(11):886-90. DOI: 10.1016/s0960-9822(01)00238-x. View

Litchfield D, Luscher B, Lozeman F, Eisenman R, KREBS E . Phosphorylation of casein kinase II by p34cdc2 in vitro and at mitosis. J Biol Chem. 1992; 267(20):13943-51. View

Meek D, Simon S, Kikkawa U, Eckhart W . The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II. EMBO J. 1990; 9(10):3253-60. PMC: 552058. DOI: 10.1002/j.1460-2075.1990.tb07524.x. View

Litchfield D, Lozeman F, Cicirelli M, Harrylock M, Ericsson L, Piening C . Phosphorylation of the beta subunit of casein kinase II in human A431 cells. Identification of the autophosphorylation site and a site phosphorylated by p34cdc2. J Biol Chem. 1991; 266(30):20380-9. View

Krek W, Maridor G, Nigg E . Casein kinase II is a predominantly nuclear enzyme. J Cell Biol. 1992; 116(1):43-55. PMC: 2289274. DOI: 10.1083/jcb.116.1.43. View

10.

Ambrosini G, Adida C, Sirugo G, Altieri D . Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem. 1998; 273(18):11177-82. DOI: 10.1074/jbc.273.18.11177. View

11.

Mahotka C, Wenzel M, Springer E, Gabbert H, Gerharz C . Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 2000; 59(24):6097-102. View

12.

Colnaghi R, Wheatley S . Liaisons between survivin and Plk1 during cell division and cell death. J Biol Chem. 2010; 285(29):22592-604. PMC: 2903399. DOI: 10.1074/jbc.M109.065003. View

13.

Wheatley S, Barrett R, Andrews P, Medema R, Morley S, Swedlow J . Phosphorylation by aurora-B negatively regulates survivin function during mitosis. Cell Cycle. 2007; 6(10):1220-30. DOI: 10.4161/cc.6.10.4179. View

14.

Jones M, Padilla O, Webb N, Norng M . The anti-apoptosis protein, survivin, mediates gastric epithelial cell cytoprotection against ethanol-induced injury via activation of the p34(cdc2) cyclin-dependent kinase. J Cell Physiol. 2008; 215(3):750-64. PMC: 2288653. DOI: 10.1002/jcp.21358. View

15.

Tapia J, Torres V, Rodriguez D, Leyton L, Quest A . Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription. Proc Natl Acad Sci U S A. 2006; 103(41):15079-84. PMC: 1622780. DOI: 10.1073/pnas.0606845103. View

16.

Noton E, Colnaghi R, Tate S, Starck C, Carvalho A, Ko Ferrigno P . Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis. J Biol Chem. 2005; 281(2):1286-95. DOI: 10.1074/jbc.M508773200. View

17.

Desagher S, Osen-Sand A, Montessuit S, Magnenat E, Vilbois F, HOCHMANN A . Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol Cell. 2001; 8(3):601-11. DOI: 10.1016/s1097-2765(01)00335-5. View

18.

Daum J, Gorbsky G . Casein kinase II catalyzes a mitotic phosphorylation on threonine 1342 of human DNA topoisomerase IIalpha, which is recognized by the 3F3/2 phosphoepitope antibody. J Biol Chem. 1998; 273(46):30622-9. DOI: 10.1074/jbc.273.46.30622. View

19.

Duncan J, Litchfield D . Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim Biophys Acta. 2007; 1784(1):33-47. DOI: 10.1016/j.bbapap.2007.08.017. View

20.

Yamane K, Kinsella T . CK2 inhibits apoptosis and changes its cellular localization following ionizing radiation. Cancer Res. 2005; 65(10):4362-7. DOI: 10.1158/0008-5472.CAN-04-3941. View